Glyph Translation — A professional language service partner dedicated to the pharmaceutical and life sciences sectors. We focus on the core needs of global pharmaceutical enterprises, providing full-chain services including high-quality translation, eCTD publishing, clinical trial document processing, international registration consulting, and brand promotion.
With years of dedicated industry experience, we have delivered professional solutions to thousands of international pharmaceutical, medical device, and health supplement companies, with services spanning key areas such as clinical research, drug registration, conference services, academic papers, and marketing materials.


  • 80+

    Services in 80+ Languages Worldwide

  • 500+

    Cumulative Pharmaceutical Projects Completed

  • 50+

    50+ Intellectual Property Rights

  • 4+

    4 ISO Certifications

  • 3000+

    3,000+ Conference Service Annually

  • 99.68%

    99.68% Client Satisfaction Rate and Delivery Success Rate

  • 3000+

    Partnering with over 3,000 companies, including large CROs,

  • 60+

    Registration Support Experience in 60+ Countries and Regions

Glyph Translation has built a team of over 2,500 professionals and delivers more than 300 million words of translation annually. Our services extend to 150+ countries and regions, helping enterprises expand across global markets and strengthen their international competitiveness.

Centered on customer needs, we provide customized solutions precisely tailored to the pharmaceutical sector.
/With precise, intelligent, and professional services, we help pharmaceutical companies expand into global markets efficiently and compliantly, ensuring a smooth and worry-free process from start to finish.
  • Deeply customized by product line and therapeutic area to precisely meet the needs of specialized use cases;

    Integrates CTD/eCTD engineering modules, GxP-compliant dedicated corpora, and a robust medical terminology validation engine to provide triple assurance for professionalism and compliance;

    A fully integrated end-to-end workflow engine combined with a dynamic knowledge management system enables experience reuse and continuous efficiency gains.

  • A 12-node, real-time end-to-end tracking dashboard covering key stages including eCTD document breakdown, medical translation and review, DTP publishing, and regulatory compliance quality control;

    Built-in GxP audit-ready mechanisms and intelligent risk alert modules help proactively mitigate registration risks and keep project timelines under control;

    Visual dashboards provide a clear, at-a-glance view of project status and compliance milestones for efficient collaborative management.

  • Our proprietary NMT engine is deeply tailored to medical scenarios and continuously trained and optimized on clients' private corpora, becoming more accurate with ongoing use;

    It accumulates extensive domain expertise to mirror each client's preferred language style, writing logic, and terminology conventions;

    By integrating intelligent review and refinement, it significantly improves translation consistency and professionalism while reducing manual review costs.

  • Focused on the R&D of AI-powered interactive translation systems and the development of knowledge graphs for specialized medical domains, driving breakthroughs in key technologies;

    In collaboration with SIAT, BFSU, SMU, Sangfor, and other industry-academia-research partners, we are building a shared technology ecosystem;

    We promote the deep integration of translation technology with the medical and regulatory sectors to establish an industry-leading technology framework.

  • A pool of 2,000+ certified medical experts covering multiple therapeutic areas and regulatory registration scenarios;

    Real-time updates on translators' performance data for regulatory document approvals enable precise matching of high-quality resources;

    Indication-based knowledge graphs are automatically linked to achieve intelligent matching between expert resources and project needs.

  • Our proprietary TQE+TQA+TQC triple full-process review system builds a robust quality firewall;

    Automated comparison of regulatory templates and intelligent detection of critical errors improve efficiency by more than 35%;

    It enables zero technical rejection of registration documents, providing critical assurance for successful regulatory submissions.

    The translation of vaccine production batch records and quality standards demands strict attention to detail. Glyph Translation's translations provided meticulous descriptions of process parameters and testing methods, with unified terminology and zero deviation. Their timely response to remediation translations for GMP audits helped us successfully pass multiple domestic and international audits. They are highly trustworthy!”

    —— Kangtai Biological Products

    The translation of GMP documents and registration dossiers for blood purification products is highly specialized. Glyph Translation's translators deeply understood the product processes and regulatory requirements. The translation of manufacturing workflows and quality standards was precise and error-free. Supplementary revisions for NMPA registration were completed within 24 hours, helping our products gain rapid approval and launch.”

    —— Jafron Biomedical

    Glyph Translation's translation of full-module eCTD dossiers is an industry benchmark! Not only does it precisely adapt to the dual regulatory standards of the FDA and EMA, but terminology consistency is also 100%. Even with a 3-day expedited delivery for a 10,000-word clinical summary report, there were zero errors. The project team synchronized progress in real time throughout the process, helping us significantly shorten our global submission cycle. They are a core partner worthy of long-term commitment.”

    —— AstraZeneca

    As a global innovative pharmaceutical company deeply engaged in the oncology field, the global submission of our ADC drugs (such as T-DXd and Dato-DXd) requires extremely high translation precision and compliance. Glyph Translation perfectly completed the multilingual translation of Clinical Trial Reports and NDA/BLA submission dossiers, precisely adapting to the quadruple standards of the NMPA, FDA, EMA, and PMDA. The core technical terminology of ADC drugs was unified without deviation, and confidentiality measures were rigorous. They also assisted in interpreting cross-national regulatory differences, helping multiple innovative drugs like Enhertu® successfully enter the global market. Their professional capabilities are impeccable!”

    —— Daiichi Sankyo

    Deeply engaged in the fields of liver disease and oncology drugs, our overseas submission needs are frequent and stringent. Glyph Translation's translation of DMF files and IND application materials perfectly adapted to FDA/EMA standards. The translation of terminology related to innovative oncology drugs was precise, and the clinical data logic was coherent. They also assisted in interpreting overseas regulatory feedback, providing critical support for the successful launch of products like Penpulimab in European and American markets. The collaboration was professional and worry-free!”

    —— Chia Tai Tianqing

    The translation needs for multi-regional registration dossiers were scattered, involving multiple languages such as Chinese, English, Spanish, and Russian. Glyph Translation's multilingual team responded rapidly, and the translations for each language complied with local regulatory standards. There were no review issues caused by differences in expression habits, and the submission pass rate remained at the forefront of the industry.”

    —— Sinopharm
Global Consultation Hotline:400 680 7218
21st Floor, Building 19, Zhonghai Xin Innovation Industry City, Jihua Street, Longgang District, Shenzhen